Protease Inhibitors (Antiretroviral Drugs)

Protease inhibitors and antiretrovirals anchor the debate as contested lifeline—$150 weekly under patents, black market alternatives—framing Nimbala's Norway pricing plea, corruption dodges, and Josh's per-patient dosing, their regimen tyranny symbolizing delivery chasms beyond mere affordability.

Protease inhibitors are invoked by Spokesman 2 as key to the triple cocktail—two every eight hours—exemplifying the regimen's tyrannical precision that demands wristwatches, shifting narrative from patent costs to adherence impossibilities in Africa's context.

Protease inhibitors referenced as core to the triple cocktail—two every eight hours—by Spokesman 2, embodying regimen's punishing precision that crumbles without African timekeeping, shifting narrative from patent costs to adherence chasm and silencing idealists.